Vistra partners with AMR Action Fund

Related Topics

Vistra, a provider of advisory and administrative support to Private Equity and Venture Capital Fund, Corporate, Capital Market and Private Wealth clients, has formed a strategic partnership with the AMR Action Fund, a public-private partnership supporting the development of new antibiotics. 

Vistra was chosen by the AMR Action Fund to provide fund administration and a multi-country, multi-service solution to enable them in their goal to bring two to four new antibiotics to market by the end of the decade.
 
The AMR Action Fund, a global venture capital fund, is an initiative of the international body representing the R&D pharmaceutical industry (International Federation of Pharmaceutical Manufacturers & Associations, IFPMA), in collaboration with the World Health Organisation, the European Investment Bank, and the Wellcome Trust. It aims to accelerate the development of new antibiotics by investing more than USD1 billion in smaller biotech companies and providing industry expertise to support the clinical development of novel antibiotics.
 
With USD370 billion of AUA globally, Vistra supports the AMR Action Fund across their entire fund structure, the management company, the fund, its SPVs and portfolio company investments. These services enable the AMR Action Fund to focus on sourcing the investments across their US and Luxembourg Funds.
 
Henry Skinner, CEO at AMR Action Fund, says: “AMR is a global issue that could have public health and economic consequences greater than Covid-19. We need to act swiftly and purposefully to address the threat and working with Vistra has enabled us to do that. Their solutions and services have been instrumental in helping us build momentum quickly. We value partnering with those who share in our vision and who help create market conditions that enable sustainable investment in the antibiotic pipeline.”
 
“Combining our global fund administration expertise with our corporate and advisory services into one tailored solution was key to helping the AMR Action Fund to build their operations quickly across the world – ensuring strong foundations were put in place while complying with all the required regulations. We’re delighted that Vistra has been able to provide these essential services so that the AMR Action Fund can focus their efforts on what they do best – making the right investments to address an important health issue,” says Onno Bouwmeister, Vistra Global Head Private Equity and Real Estate.
 
Vistra works with a number of the leading Private Equity and not-for-profit investment funds around the world. Vistra’s capabilities enable investment organisations around the world to grow, manage, structure and transact their investment opportunities with a range of industry leading services. 

Author Profile